DrugPatentWatch Database Preview
Barr Labs Inc Company Profile
» See Plans and Pricing
What is the competitive landscape for BARR LABS INC, and what generic and branded alternatives to BARR LABS INC drugs are available?
BARR LABS INC has seventeen approved drugs.
There are two tentative approvals on BARR LABS INC drugs.
Summary for Barr Labs Inc
| US Patents: | 0 |
| Tradenames: | 16 |
| Ingredients: | 15 |
| NDAs: | 17 |
Drugs and US Patents for Barr Labs Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Barr Labs Inc | METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 079031-004 | Oct 15, 2014 | DISCN | No | No | Start Trial | Start Trial | |||||
| Barr Labs Inc | OLOPATADINE HYDROCHLORIDE | olopatadine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 090848-001 | Jul 13, 2015 | AT | RX | No | No | Start Trial | Start Trial | ||||
| Barr Labs Inc | METHYLPHENIDATE HYDROCHLORIDE | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 079031-002 | Jul 13, 2012 | DISCN | No | No | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
